Clinical Trials Research on cancer, older people, and cardiovascular disease
The CTRU is a NHS-funded, National Cancer Research Institute (NCRI) accredited and UKCRC Registered research unit based at the University of Leeds within Leeds Institute of Molecular Medicine. It has a national and international reputation for conducting complex, multi-centre clinical trials. The CTRU works with NHS partners and University colleagues, providing academic support and infrastructure to enable local, national and international researchers, design and undertake high quality, rigorous, multi-centre trials to MRC/ICH Good Clinical Practice (GCP) guidelines. The CTRU is a strong unit and underpins a large amount of trials work undertaken in the UK.
The CTRU provides multi-disciplinary academic leadership for the development and management of rigorous clinical trials, with input to all aspects of trials activity, including statistical design, protocol development, randomisation, development of outcome measures, data management, logistical issues, statistical analysis, interpretation of results and publication. Both the CTRU’s track record in conducting complex clinical trials and its associated methodological research (for example recruitment into trials and quality of life measures) inform the academic development of this specialised field of clinical research on a national and international level.
The CTRU is a Coordinating Centre Clinical Trials Unit (CTU) for both the National Clinical Research Network and National Cancer Research Network (NCRN), and senior members of the CTRU multidisciplinary trialist team have contributed significantly to national activity providing the trialists perspective to developments in the clinical research field to maximise accrual of UK NHS patients into clinical trials.
The CTRU is organised into four divisions, within which the portfolios reflect both national priorities and strengths in Leeds: